492934624	492934624	CD	B-NP	O
|	|	NN	I-NP	O
SCH	SCH	NN	I-NP	O
|	|	NN	I-NP	O
53918985	53918985	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2335381	2335381	CD	B-NP	O
|	|	CC	I-NP	O
10/1/2007	10/1/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Chest	Chest	NNP	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/26/2007	7/26/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/9/2007	8/9/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
TAFEL	TAFEL	NNP	B-NP	O
,	,	,	O	O
FERNANDO	FERNANDO	NNP	B-NP	O
M	M	NNP	I-NP	O
460-39-19-7	460-39-19-7	CD	I-NP	O
Lau	Lau	NNP	I-NP	O
Mawau	Mawau	NNP	I-NP	O
Rance	Rance	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
1/27/07	1/27/07	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ABEYTA	ABEYTA	NNP	B-NP	O
,	,	,	O	O
JULES	JULES	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

ALBUTEROL	ALBUTEROL	NN	B-NP	B-protein
INHALER	INHALER	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
QID	QID	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

AMLODIPINE	AMLODIPINE	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

ASPIRIN	ASPIRIN	NNP	B-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	VBD	B-VP	O
325	325	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

CLOPIDOGREL	CLOPIDOGREL	NN	B-NP	O
75	75	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

ENALAPRIL	ENALAPRIL	NN	B-NP	O
MALEATE	MALEATE	VBP	B-VP	O
20	20	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

GABAPENTIN	GABAPENTIN	NN	B-NP	B-protein
300	300	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

IBUPROFEN	IBUPROFEN	NN	B-NP	B-protein
600	600	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q6H	Q6H	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

OMEGA-3-FATTY	OMEGA-3-FATTY	NN	B-NP	O
ACIDS	ACIDS	NN	I-NP	O
2000	2000	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

PAROXETINE	PAROXETINE	NN	B-NP	O
CONTROLLED	CONTROLLED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	O
25	25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

PYRIDOXINE	PYRIDOXINE	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
11	11	CD	I-NP	I-protein
.	.	.	O	O

CARVEDILOL	CARVEDILOL	NN	B-NP	O
6.25	6.25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

ROSUVASTATIN	ROSUVASTATIN	NN	B-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

FLUTICASONE	FLUTICASONE	NN	B-NP	B-protein
PROPIONATE	PROPIONATE	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
14	14	CD	I-NP	I-protein
.	.	.	O	O

FOLIC	FOLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	O
25	25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

METFORMIN	METFORMIN	NN	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

ESOMEPRAZOLE	ESOMEPRAZOLE	RB	B-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

FENOFIBRATE	FENOFIBRATE	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
TRICOR	TRICOR	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
19	19	CD	I-NP	O
.	.	.	O	O

HYDROCODONE	HYDROCODONE	NN	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
+	+	SYM	B-VP	O
APAP	APAP	NN	B-NP	O
500MG	500MG	CD	I-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

CYANOCOBALAMIN	CYANOCOBALAMIN	NN	B-NP	B-protein
500	500	CD	I-NP	I-protein
MCG	MCG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
21	21	CD	I-NP	I-protein
.	.	.	O	O

INDOMETHACIN	INDOMETHACIN	NN	B-NP	O
25	25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

LIPITOR	LIPITOR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/19/07	2/19/07	CD	B-NP	O
by	by	IN	B-PP	O
FEDER	FEDER	NNP	B-NP	O
,	,	,	O	O
FABIAN	FABIAN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FENOFIBRATE	FENOFIBRATE	NNP	B-NP	O
,	,	,	I-NP	O
MICRONIZED	MICRONIZED	NNP	I-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COREG	COREG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CARVEDILOL	CARVEDILOL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
6.25	6.25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ENALAPRIL	ENALAPRIL	NNP	I-NP	O
MALEATE	MALEATE	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
TRICOR	TRICOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TRICOR	TRICOR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
145	145	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/19/07	2/19/07	CD	B-NP	O
by	by	IN	B-PP	O
SJOQUIST	SJOQUIST	NN	B-NP	O
,	,	,	O	O
HUGH	HUGH	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LIPITOR	LIPITOR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
074155804	074155804	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FENOFIBRATE	FENOFIBRATE	NNP	B-NP	O
,	,	,	I-NP	O
MICRONIZED	MICRONIZED	NNP	I-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	I-NP	O
25	25	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PAROXETINE	PAROXETINE	NNP	I-NP	O
CONTROLLED	CONTROLLED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Your	Your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Conely	Conely	NNP	I-NP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
had	have	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
April	April	NNP	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
pain	pain	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Spinal	Spinal	NNP	I-NP	O
Stenosis	Stenosis	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
spinal	spinal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OSA	OSA	NN	I-NP	O
on	on	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hyperhomocysteinemia	Hyperhomocysteinemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hyperhomocysteinemia	hyperhomocysteinemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
elevated	elevate	VBD	B-VP	O
Lp	Lp	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
A	A	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Hyperlipidemia	Hyperlipidemia	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
LBP	LBP	NN	I-NP	O
and	and	CC	O	O
RLE	RLE	NN	B-NP	O
radiculopathy	radiculopathy	NN	I-NP	O
Reiter	Reiter	NNP	B-NP	O
's	's	POS	B-NP	O
like	like	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Reiters	Reiters	NNP	I-NP	O
syndrome	syndrome	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
microcytic	microcytic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
microcytic	microcytic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
glucose	glucose	NN	I-NP	O
intolerance	intolerance	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
glucose	glucose	NN	I-NP	O
intolerance	intolerance	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cardiac	Cardiac	NNP	I-NP	O
Stress	Stress	NNP	I-NP	O
PET	PET	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Chest	Ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
52	52	CD	B-NP	O
yo	yo	NN	I-NP	O
M	M	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
DM	DM	NN	I-NP	O
,	,	,	O	O
dyslipidemia	dyslipidemia	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
2v	2v	NN	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
'02	'02	NN	B-NP	O
for	for	IN	B-PP	O
RCA	RCA	NN	B-NP	O
dissection	dissection	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
complication	complication	NN	I-NP	O
of	of	IN	B-PP	O
PCI	PCI	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
LIMA	LIMA	NN	I-NP	B-protein
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
radial	radial	NN	B-NP	O
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
s/p	s/p	VB	B-VP	O
multiple	multiple	JJ	B-NP	O
catheterizations	catheterization	NNS	I-NP	O
for	for	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
and	and	CC	O	O
instent	instent	JJ	B-NP	O
restenosis	restenosis	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
atypical	atypical	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
his	his	PRP$	B-NP	O
last	last	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
in	in	IN	B-PP	O
10/24	10/24	CD	B-NP	O
for	for	IN	B-PP	O
re-stenting	re-stenting	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
LCx	LCx	NN	I-NP	B-protein
,	,	,	O	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
pain	pain	RB	B-ADJP	O
free	free	JJ	I-ADJP	O
,	,	,	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
about	about	RB	B-NP	O
1/2	1/2	CD	I-NP	O
mile	mile	NN	I-NP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
pt	pt	NN	I-NP	O
woke	wake	VBD	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
sharp	sharp	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
diaphoresis	diaphoresis	NN	B-NP	O
and	and	CC	O	O
tingling	tingle	VBG	B-VP	O
down	down	RP	B-PRT	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
pressure	pressure	NN	I-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
felt	feel	VBN	I-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
admissions	admission	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
stenosis	stenosis	NN	B-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
was	be	VBD	B-VP	O
described	describe	VBN	I-VP	O
as	as	IN	B-PP	O
sharp	sharp	JJ	B-NP	O
9/10	9/10	CD	I-NP	O
that	that	WDT	B-NP	O
improved	improve	VBD	B-VP	O
after	after	IN	B-PP	O
taking	take	VBG	B-VP	O
his	his	PRP$	B-NP	O
second	second	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
ntg	ntg	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
and	and	CC	I-NP	O
arm	arm	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
resolved	resolve	VBD	B-VP	O
concurrently	concurrently	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
third	third	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
ntg	ntg	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
EMS	EMS	NNP	I-NP	O
and	and	CC	O	O
brought	bring	VBD	B-VP	O
to	to	TO	B-PP	O
ED	ED	NNP	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
ago	ago	IN	B-ADVP	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
struck	strike	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
center	center	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
by	by	IN	B-PP	O
teenagers	teenager	NNS	B-NP	O
``	``	``	O	O
horsing	horse	VBG	B-VP	O
around	around	RB	B-ADVP	O
''	''	''	O	O
next	next	JJ	B-VP	O
to	to	TO	B-PP	O
him	him	PRP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
impact	impact	NN	I-NP	O
was	be	VBD	B-VP	O
severe	severe	JJ	B-ADJP	O
enough	enough	RB	I-ADJP	O
to	to	TO	B-VP	O
cause	cause	VB	I-VP	O
him	him	PRP	B-NP	O
to	to	TO	B-VP	O
fall	fall	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ground	ground	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
noticed	notice	VBD	B-VP	O
pain	pain	NN	B-NP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
that	that	IN	B-NP	O
he	he	PRP	B-NP	O
described	describe	VBD	B-VP	O
as	as	IN	B-PP	O
more	more	JJR	B-NP	O
pressure	pressure	NN	I-NP	O
like	like	IN	B-PP	O
different	different	JJ	B-NP	O
from	from	IN	B-PP	O
what	what	WP	B-NP	O
he	he	PRP	B-NP	O
felt	feel	VBD	B-VP	O
like	like	IN	B-PP	O
this	this	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
noticed	notice	VBD	B-VP	O
that	that	IN	B-SBAR	O
since	since	IN	B-SBAR	O
the	the	DT	B-NP	O
incident	incident	NN	I-NP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
more	more	RBR	B-ADJP	O
tired	tired	JJ	I-ADJP	O
than	than	IN	B-PP	O
usual	usual	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	JJ	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
hemodyanmically	hemodyanmically	RB	B-ADVP	O
stable	stable	JJ	B-NP	O
HR	HR	NN	I-NP	O
54-57	54-57	CD	B-NP	O
BP	BP	NN	I-NP	O
113-142/64	113-142/64	CD	B-NP	O
-78	-78	CD	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-NP	O
breathing	breathing	NN	I-NP	O
at	at	IN	B-PP	O
18/min	18/min	NN	B-NP	O
O2	O2	NN	I-NP	O
sat	sit	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
another	another	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
ntg	ntg	NN	B-NP	B-protein
by	by	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
spray	spray	NN	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
Dilaudid	Dilaudid	VBD	B-VP	O
1mg	1mg	NN	B-NP	O
for	for	IN	B-PP	O
back	back	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75mg	75mg	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
lovenox	lovenox	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

=	=	SYM	O	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
CARDS	CARDS	NN	B-NP	O
HX	HX	NN	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
:	:	:	O	O
-	-	SYM	B-NP	O
9/10/2006	9/10/2006	CD	B-NP	O
cath	cath	NN	I-NP	O
:	:	:	O	O
p/w	p/w	NN	B-NP	O
CP	CP	NN	I-NP	O
,	,	,	O	O
negative	negative	JJ	B-NP	O
biomarkers	biomarker	NNS	I-NP	O
,	,	,	O	O
adenosine	adenosine	NN	B-NP	O
MIBI	MIBI	NN	I-NP	O
+	+	SYM	B-NP	O
ve	ve	NN	I-NP	O
for	for	IN	B-PP	O
reversible	reversible	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
,	,	,	O	O
patent	patent	NN	B-NP	O
grafts	graft	NNS	I-NP	O
,	,	,	O	O
instent	instent	JJ	B-NP	O
restenosis	restenosis	NN	I-NP	O
of	of	IN	B-PP	O
LCx	LCx	NN	B-NP	B-protein
stented	stente	VBD	B-VP	O
with	with	IN	B-PP	O
TAXUS	TAXUS	NN	B-NP	B-protein
-	-	HYPH	O	O
8/18/06	8/18/06	CD	B-NP	O
cath	cath	NN	I-NP	O
:	:	:	O	O
Neg	Neg	NN	B-NP	O
enz	enz	NN	I-NP	O
,	,	,	O	O
TWI	TWI	NN	B-NP	O
V4-V6	V4-V6	NN	I-NP	O
,	,	,	O	O
patent	patent	NN	B-NP	O
grafts	graft	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
new	new	JJ	I-NP	O
disease	disease	NN	I-NP	O
-	-	HYPH	O	O
9/12/04	9/12/04	CD	B-NP	O
cath	cath	NN	I-NP	O
:	:	:	O	O
Instent	Instent	JJ	B-NP	O
restenosis	restenosis	NN	I-NP	O
of	of	IN	B-PP	O
LCx	LCx	NN	B-NP	B-protein
from	from	IN	B-PP	O
'03	'03	CD	B-NP	O
,	,	,	O	O
stent	stent	JJ	B-ADJP	O
with	with	IN	B-PP	O
Cypher	Cypher	NNP	B-NP	O
-	-	HYPH	O	O
10/27/04	10/27/04	CD	B-NP	O
cath	cath	NN	I-NP	O
for	for	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
,	,	,	O	O
no	no	DT	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
negative	negative	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
?	?	.	O	O

ECG	ECG	NN	B-NP	O
changes	change	NNS	I-NP	O
-	-	:	O	O
10/19/03	10/19/03	CD	B-NP	O
:	:	:	O	O
cutting	cut	VBG	B-VP	O
balloon	balloon	NN	B-NP	O
inflation	inflation	NN	I-NP	O
and	and	CC	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
pPDA	pPDA	NN	I-NP	O
stent	stent	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
drug	drug	NN	I-NP	O
eluting	elute	VBG	B-VP	O
-RRB-	-RRB-	SYM	B-NP	B-protein
-	-	HYPH	B-NP	O
3/7	3/7	CD	I-NP	O
02	02	CD	I-NP	O
CABG	CABG	NN	I-NP	O
s/p	s/p	NN	I-NP	O
RCA	RCA	NN	I-NP	O
dissection	dissection	NN	I-NP	O
from	from	IN	B-PP	O
PCTA	PCTA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
below	below	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
required	require	VBD	B-VP	O
IABP	IABP	NN	B-NP	B-protein
-	-	HYPH	O	O
2/9/02	2/9/02	CD	B-NP	O
instent	instent	JJ	I-NP	O
restenosis	restenosis	NN	I-NP	O
of	of	IN	B-PP	O
LCx	LCx	NN	B-NP	B-protein
PCTA	PCTA	NN	I-NP	I-protein
of	of	IN	B-PP	O
OM2	OM2	NN	B-NP	B-protein
,	,	,	O	O
RCA	RCA	NN	B-NP	B-protein
-	-	HYPH	O	O
1/30/02	1/30/02	CD	B-NP	O
PCTA	PCTA	NN	I-NP	O
of	of	IN	B-PP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
occl	occl	NN	I-NP	O
of	of	IN	B-PP	O
pLAD	pLAD	NN	B-NP	O
-	-	HYPH	O	O
5/6/01	5/6/01	CD	B-NP	O
PCTA	PCTA	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
occl	occl	NN	I-NP	O
of	of	IN	B-PP	O
LCx	LCx	NN	B-NP	O
Heart	Heart	NN	I-NP	O
failure	failure	NN	I-NP	O
DM2	DM2	NN	I-NP	O
Hypercholesterolemia	Hypercholesterolemia	NN	I-NP	O
HTN	HTN	NN	I-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
OTHER	OTHER	NN	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
Costocondritis	Costocondritis	NN	B-NP	O
H/o	H/o	NN	I-NP	O
slightly	slightly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
anticardiolipin	anticardiolipin	NN	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
-LRB-	-LRB-	SYM	O	I-protein
5/6/01	5/6/01	CD	B-NP	I-protein
admission	admission	NN	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
OSA	OSA	NNP	I-NP	I-protein
Chronic	Chronic	NNP	I-NP	I-protein
back	back	RB	B-ADVP	I-protein
pain	pain	NN	B-NP	I-protein
-	-	HYPH	O	O
herniated	herniate	VBN	B-NP	O
disc	disc	NN	I-NP	O
from	from	IN	B-PP	O
work	work	NN	B-NP	O
Arthritis	Arthritis	NN	I-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
HOME	HOME	NN	B-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
Albuterol	Albuterol	NN	B-NP	B-protein
prn	prn	NN	I-NP	I-protein
Fluticasone	Fluticasone	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
mcg	mcg	NN	I-NP	I-protein
qam	qam	NN	I-NP	I-protein
Amlodipine	Amlodipine	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
qd	qd	NN	I-NP	I-protein
ASA	ASA	NN	I-NP	I-protein
325	325	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
qd	qd	NN	I-NP	I-protein
Coreg	Coreg	NN	I-NP	I-protein
6.25	6.25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
bid	bid	RB	B-ADVP	I-protein
Plavix	Plavix	NNP	B-NP	I-protein
75	75	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
qd	qd	NN	I-NP	I-protein
Vitamin	Vitamin	NN	I-NP	I-protein
B12	B12	NN	I-NP	I-protein
500	500	CD	I-NP	I-protein
mcg	mcg	NN	I-NP	I-protein
qd	qd	NN	I-NP	I-protein
Enalapril	Enalapril	NNP	B-NP	I-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
bid	bid	RB	B-ADVP	O
Nexium	Nexium	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
Tricor	Tricor	NNP	B-NP	O
145	145	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
Folate	Folate	NN	I-NP	O
1mg	1mg	NN	I-NP	O
qd	qd	NN	I-NP	O
Neurontin	Neurontin	NN	I-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
bid	bid	RB	B-ADVP	O
Vicodin	Vicodin	NNP	B-NP	O
1	1	CD	I-NP	O
tab	tab	NN	I-NP	O
q6h	q6h	NN	I-NP	O
prn	prn	NN	I-NP	O
Ibuprofen	Ibuprofen	NN	I-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
q6h	q6h	NN	I-NP	O
prn	prn	NN	I-NP	O
Metformin	Metformin	NN	I-NP	O
00	00	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
Omega	Omega	NN	I-NP	O
3	3	CD	I-NP	O
fatty	fatty	JJ	I-NP	O
acid	acid	NN	I-NP	O
2000	2000	CD	I-NP	O
mg	mg	NN	I-NP	O
bid	bid	RB	B-ADVP	O
Paroxetine	Paroxetine	NN	B-NP	O
controlled	controlled	JJ	I-NP	O
release	release	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
Vitamin	Vitamin	NN	I-NP	O
B6	B6	NN	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
Crestor	Crestor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
Indocin	Indocin	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
tid	tid	NN	I-NP	O
Hctz	Hctz	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
ADMISSION	ADMISSION	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
Temp	Temp	NN	B-NP	O
96.1	96.1	CD	B-NP	O
HR	HR	NN	I-NP	O
59	59	CD	B-NP	O
BP	BP	NN	I-NP	O
140/80	140/80	CD	B-NP	O
RR	RR	NN	I-NP	O
20	20	CD	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
Tired	Tire	VBN	B-VP	O
appearing	appear	VBG	B-VP	O
,	,	,	O	O
obese	obese	JJ	B-NP	O
African	African	JJ	I-NP	O
American	American	JJ	I-NP	O
man	man	NN	I-NP	O
lying	lie	VBG	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
pleasant	pleasant	NN	B-NP	O
,	,	,	O	O
A	A	NNP	B-NP	O
&	&	CC	I-NP	B-protein
O	O	NNP	I-NP	I-protein
x3	x3	NN	I-NP	I-protein
in	in	IN	B-PP	O
NAD	NAD	NN	B-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
nl	nl	NN	B-NP	O
conjunctiva	conjunctiva	NN	I-NP	O
,	,	,	O	O
anicteric	anicteric	NN	B-NP	O
,	,	,	O	O
PERRLA	PERRLA	NN	B-NP	O
,	,	,	O	O
EOMI	EOMI	NN	B-NP	B-protein
,	,	,	O	O
mmm	mmm	NN	B-NP	O
,	,	,	O	O
oropharynx	oropharynx	NN	B-NP	O
clear	clear	JJ	I-NP	O
Neck	Neck	NN	I-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
approx	approx	RB	B-NP	O
6	6	CD	I-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
thyroid	thyroid	NN	B-NP	O
not	not	RB	O	O
palpable	palpable	JJ	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
pain	pain	NN	B-NP	O
with	with	IN	B-PP	O
light	light	JJ	B-NP	O
palpation	palpation	NN	I-NP	O
most	most	RBS	B-ADJP	O
signficant	signficant	JJ	I-ADJP	O
on	on	IN	B-PP	O
lower	low	JJR	B-NP	O
left	left	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
S2	S2	NN	I-NP	I-protein
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
S4	S4	NN	B-NP	B-protein
heard	hear	VBD	B-VP	O
loudest	loud	JJS	B-ADJP	O
at	at	IN	B-PP	O
lower	low	JJR	B-NP	O
left	left	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
is	be	VBZ	B-VP	O
tender	tender	NN	B-NP	O
to	to	TO	B-PP	O
light	light	JJ	B-NP	O
palpation	palpation	NN	I-NP	O
Lung	Lung	NN	I-NP	O
:	:	:	O	O
CTAB	CTAB	NN	B-NP	B-protein
Abd	Abd	NN	I-NP	O
:	:	:	O	O
+	+	SYM	B-NP	O
BS	BS	NN	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
NT	NT	NNP	B-NP	O
,	,	,	O	O
ND	ND	NNP	B-NP	O
Ext	Ext	NNP	I-NP	O
:	:	:	O	O
WWP	WWP	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
CCE	CCE	NN	I-NP	O
,	,	,	O	O
Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
nonfocal	nonfocal	JJ	B-ADJP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
STUDIES	STUDIES	NNS	B-NP	O
:	:	:	O	O
CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
cardiopulmonary	cardiopulmonary	JJ	I-NP	O
process	process	NN	I-NP	O
STRESS	STRESS	NN	I-NP	O
PET	PET	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
PET-CT	PET-CT	NN	I-NP	O
test	test	NN	I-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
normal	normal	JJ	B-ADJP	O
and	and	CC	O	O
suggest	suggest	VBP	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
flow-limiting	flow-limiting	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
global	global	JJ	I-NP	O
LV	LV	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
interval	interval	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2006	2006	CD	B-NP	O
.	.	.	O	O

=	=	SYM	O	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
CONSULTS	CONSULTS	NNS	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHEST	CHEST	NN	I-NP	O
PAIN	PAIN	NN	I-NP	O
On	On	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
pain	pain	NN	B-NP	O
free	free	JJ	B-ADJP	O
but	but	CC	O	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
experience	experience	VB	I-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
ntg	ntg	NN	B-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
compazine	compazine	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
nausea	nausea	NN	I-NP	O
was	be	VBD	B-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
ischemia	ischemia	NN	B-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
dilaudid	dilaudid	NN	B-NP	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
ECG	ECG	NN	I-NP	B-protein
changes	change	VBZ	B-VP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

Altogether	Altogether	RB	B-ADVP	O
the	the	DT	B-NP	O
nausea	nausea	NN	I-NP	O
lasted	last	VBN	B-VP	O
for	for	IN	B-PP	O
approximately	approximately	RB	B-NP	O
10	10	CD	I-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
remained	remain	VBD	B-VP	O
pain	pain	NN	B-ADJP	O
free	free	JJ	I-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
with	with	IN	B-PP	O
what	what	WP	B-NP	O
he	he	PRP	B-NP	O
described	describe	VBD	B-VP	O
as	as	IN	B-PP	O
some	some	DT	B-NP	O
slight	slight	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
over	over	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
chest	chest	NN	I-NP	O
is	be	VBZ	B-VP	O
tender	tender	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
ever	ever	RB	B-ADVP	O
since	since	IN	B-PP	O
his	his	PRP$	B-NP	O
CABG	CABG	NN	I-NP	B-protein
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
MSK	MSK	NN	B-NP	B-protein
or	or	CC	I-NP	O
cardiac	cardiac	NN	I-NP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
sometimes	sometimes	RB	B-ADVP	O
felt	feel	VBD	B-VP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
first	first	RB	B-ADVP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
at	at	IN	B-PP	O
other	other	JJ	B-NP	O
times	time	NNS	I-NP	O
he	he	PRP	B-NP	O
describes	describe	VBZ	B-VP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
as	as	IN	B-PP	O
being	be	VBG	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
movement	movement	NN	B-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
kick	kick	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	B-protein
received	receive	VBD	B-VP	I-protein
2	2	CD	B-NP	I-protein
weeks	week	NNS	I-NP	I-protein
earlier	early	JJR	B-NP	O
-LRB-	-LRB-	NN	I-NP	B-protein
see	see	VBP	B-VP	O
HPI	HPI	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Overnight	Overnight	NN	B-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
#	#	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
any	any	DT	B-NP	O
more	more	JJR	I-NP	O
NTG	NTG	NN	I-NP	B-protein
doses	dose	NNS	I-NP	I-protein
,	,	,	O	O
remained	remain	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
three	three	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
catheterizations	catheterization	NNS	B-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
restenosis	restenosis	NN	B-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
his	his	PRP$	B-NP	O
presentation	presentation	NN	I-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
atypical	atypical	JJ	I-ADJP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
to	to	TO	I-VP	O
do	do	VB	I-VP	O
a	a	DT	B-NP	O
stress	stress	NN	I-NP	O
PET	PET	NN	I-NP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
day	day	NN	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
ischemia	ischemia	NN	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
re-evaluate	re-evaluate	JJ	B-NP	O
plan	plan	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
medications	medication	NNS	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-VP	O
lovenox	lovenox	VB	I-VP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
SC	SC	NN	I-NP	O
for	for	IN	B-PP	O
ACS	ACS	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
when	when	WRB	B-ADVP	O
moving	move	VBG	B-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
chair	chair	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bed	bed	NN	I-NP	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
2/10	2/10	CD	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
that	that	IN	B-NP	O
he	he	PRP	B-NP	O
says	say	VBZ	B-VP	O
felt	feel	VBD	B-VP	O
a	a	DT	B-NP	O
little	little	RB	I-NP	O
different	different	JJ	B-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
when	when	WRB	B-ADVP	O
palpating	palpate	VBG	B-VP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

Again	Again	RB	B-ADVP	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
ECG	ECG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
stress	stress	NN	I-NP	O
PET	PET	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
his	his	PRP$	B-NP	O
presentation	presentation	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
clearly	clearly	RB	I-NP	O
negative	negative	JJ	I-NP	O
study	study	NN	I-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
were	be	VBD	B-VP	O
MSK	MSK	NN	B-NP	B-protein
in	in	IN	B-PP	O
origin	origin	NN	B-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
DM2	DM2	NN	I-NP	O
Patient	Patient	NN	I-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
hypoglycemic	hypoglycemic	JJ	I-NP	O
agents	agent	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
basal	basal	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
and	and	CC	O	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
FEN	FEN	NN	I-NP	B-protein
NPO	NPO	NN	I-NP	I-protein
for	for	IN	B-PP	O
stress	stress	NN	B-NP	O
PET	PET	NN	I-NP	O
,	,	,	O	O
K/Mg	K/Mg	NN	B-NP	B-protein
scales	scale	NNS	I-NP	I-protein
4	4	CD	B-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
PPX	PPX	NN	I-NP	B-protein
Patient	Patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
for	for	IN	B-PP	O
ACS	ACS	NNP	B-NP	O
,	,	,	O	O
PPI	PPI	NNP	B-NP	B-protein
5	5	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
Full	Full	JJ	I-NP	O
Code	Code	NN	I-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Please	Please	NN	I-NP	B-protein
take	take	VB	B-VP	O
your	your	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
VERY	VERY	NNP	B-NP	O
IMPORTANT	IMPORTANT	NNP	I-NP	O
that	that	IN	B-NP	O
you	you	PRP	B-NP	O
take	take	VBP	B-VP	O
your	your	PRP$	B-NP	O
aspirin	aspirin	NN	I-NP	O
and	and	CC	I-NP	O
plavix	plavix	NN	I-NP	O
medications	medication	NNS	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
stents	stent	NNS	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Please	Please	NN	I-NP	B-protein
see	see	VB	B-VP	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Pohl	Pohl	NNP	I-NP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
had	have	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	I-NP	O
30	30	CD	I-NP	O
pm	pm	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Please	Please	NN	I-NP	O
return	return	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
exprience	exprience	VBP	B-VP	O
pain	pain	NN	B-NP	O
that	that	WDT	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
go	go	VB	I-VP	O
away	away	RB	B-ADVP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	O
,	,	,	O	O
light	light	JJ	B-NP	O
headedness	headedness	NN	I-NP	O
,	,	,	O	O
fainting	fainting	NN	B-NP	O
,	,	,	O	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
vision	vision	NN	B-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
numbness	numbness	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
HANNON	HANNON	NNP	B-NP	O
,	,	,	O	O
KRAIG	KRAIG	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SY43	SY43	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/27/07	1/27/07	CD	I-NP	O
@	@	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
16	16	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

